EyeGate Raises $22.6M In Venture Funding

The money will be used to further the company’s development of EGP-437 to treat dry eye syndrome.

Read more »

Seaside Therapeutics Secures $30M to Fight Autism

Seaside Therapeutics has secured $30 million in funding from a private, unnamed family investment firm committed to finding treatments for autism and Fragile X syndrome.

Read more »

Jennerex Raises $5.1 Million for Oncology Pipeline

Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.

Read more »

Biotech Industry Tops for Venture Capital Investors

A new report published by PricewaterhouseCoopers and the National Venture Capital Association found that life sciences companies garnered the most investment dollars out of any industry in the second quarter of 2009.

Read more »

Clarient Files Registration Agreement With SEC

Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard.

Read more »

CNS Closes $1M Bridge Loan, Completes Clinical Trial Enrollment

The money will allow CNS Response, based in Costa Mesa, Calif., to complete an upcoming depression study.

Read more »

Transcend Medical Raises $20 Million for Glaucoma Device

VentureWire reports that Transcend Medical, a developer of devices to treat glaucoma, has raised $20 million in equity.

Read more »

ORTHOCON Announces New President, $25 Million In Financing

Big news at ORTHOCON, DeviceSpace reports. The New Jersey-based company, which develops devices that deliver therapeutics to bone, recently announced the appointment of a new CEO and the closing of $25 million in Series B funding.

Read more »